|Back to main|
Biotech Five Prime Therapeutics sets terms for $52 million IPO
9/4/2013 5:43:00 PM
By: Renaissance Capital
Five Prime Therapeutics, a clinical stage biotech developing
protein therapeutics, announced terms for its IPO on Wednesday.
The San Francisco, CA-based company plans to raise $52 million by
offering 4.0 million shares at a price range of $12 to $14. At
the midpoint of the proposed range, Five Prime Therapeutics would
command a market value of $198 million.